[1]
S. Waghmare, “Neuroprotective Effects of Calcium Channel Blockers on Parkinson’s Disease Development: A Population Cohort Study”, J Neuro Res, vol. 15, no. 3, pp. 105–116, Aug. 2025, doi: 10.14740/jnr1023.